Categories Technology

Google bids adieu to AdWords and DoubleClick brands

Alphabet’s (GOOGL) subsidiary Google has decided to rebrand its marketing and advertisement services, and as part of this decision, the company will retire its AdWords and DoubleClick brands. The search engine company is trying to simplify its ad services, making it easier for advertisers to avail of them. Google’s various advertising services have proven to be confusing for its customers in the past and the company is looking to rectify this situation.

Google announced that only the brand names would be taken off and their services would stay the same with no change in the fees. Google has bundled its marketing services into three groups – Google Ads, Google Ad Manager and Google Marketing Platform. AdWords will be renamed as Google Ads and become the primary tool for purchasing advertisements.

Google Ads will serve as a single point of entry for marketers permitting them to gain access to content on Search, Google Play Store, YouTube and other partner services. The AdMob and AdSense brands, which cater to mobile app developers and smaller websites, will remain in service.

Google Ad Manager, aimed at large vendors, will include the DoubleClick Ad Exchange product and the DoubleClick service for publishers. The Google Marketing Platform will comprise of Google Analytics and the advertiser-based DoubleClick service. While the Google Ads platform will be simpler, the Google Marketing Platform will be more sophisticated. All the services will be compatible with other third-party products.

Google’s advertising business has faced criticism over monopoly issues with the company said to be gaining control of more than half of the digital advertisement space alongside Facebook (FB). During the first quarter of 2018, Google’s advertising revenues grew 24% to approximately $27 billion. The simpler and new structure might boost this growth further.

Google ad revenue trend

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top